by Editor | May 26, 2015 | Hormones, New Research, Pharmaceutical, PMDD, PMS
Concurrent sessions on Saturday, June 6th explore unique cultural experiences of menstruation and delve into the parameters of premenstrual distress at the 21st Biennial Conference of the Society for Menstrual Cycle Research at The Center for Women’s Health and Human...
by Elizabeth Kissling | Oct 24, 2012 | Hormones, New Research, Newspapers, PMS
If PMS is a myth, then what on earth can we blame for all the lady-rage? You may have seen the article in The Star or The Globe and Mail or The Atlantic about the recently published research review by a team of medical researchers who assert that “clear evidence for a...
by Elizabeth Kissling | Jul 11, 2012 | Hormones, New Research, PMDD, PMS
Guest Post by Joan Chrisler, Connecticut College I have to admit that I have not been closely following the news about the forthcoming edition (5th) of the Diagnostic and Statistical Manual of Mental Disorders, which is expected to be published by the American...
by Elizabeth Kissling | Nov 5, 2010 | Birth Control, Health Care, Law/Legal, Pharmaceutical
An Oklahoma City news program prepared this investigation about health risks of Bayer’s best-selling birth control pill, YAZ, with dramatic personal stories. The video cannot be embedded here, but you can watch it and read the news story here. Previous...
by Elizabeth Kissling | Sep 19, 2010 | New Research, Pharmaceutical, PMDD, PMS
Some of you may recall that in my book, Capitalizing on the Curse, I argued that the addition of PMDD to the DSM-IV and the re-branding of fluoxetine HCI as Sarafem are linked. It was no coincidence that pharmaceutical manufacturer Eli Lilly sought a unique FDA...